All In MedTech

Device Trial Radar · NCT02922036

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)

Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jan 17, 2018

Primary completion

Nov 2027

Study completion Nov 2027

Sponsor

Lead sponsor
EBR Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.

Conditions

  • Heart Failure

Interventions

  • WiSE SystemDevice

    The WiSE System is an implantable cardiac system to provide LV pacing stimulation in conjunction with a co-implanted system that provides right ventricular stimulation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary SafetyTime frame: 6 Months
  2. Primary Efficacy 1Time frame: 6 Months

Locations

68 sites in 7 countries. Site status is shown where the registry gives one.

  • Heart Center Research

    Huntsville, Alabama

  • University of California, San Diego

    La Jolla, California

  • Broward Health Medical Center

    Fort Lauderdale, Florida

65 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.